Human Molecular Genetics Advance Access originally published online on July 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, No. 18 2301-2309
DOI: 10.1093/hmg/ddg242
© 2003 Oxford University Press
DNA damage induced by polyglutamine-expanded proteins
1BioGem Consortium and 2IEOS-CNR c/o Department of Molecular and Cellular Biology and Pathology, 3Department of Molecular and Cellular Biology and Pathology and 4Department of Neurology, Federico II University, Naples, Italy
Received April 17, 2003; Accepted June 11, 2003
We have developed stable cell lines expressing green fluorescent protein fusion proteins containing polyglutamine repeats of various lengths under tetracycline control. The expression of the expanded (43Q) repeat protein resulted in aggregate formation in a time-dependent fashion. The accumulation of aggregates did not induce apoptosis, although the survival of these cells was critically dependent on the presence of serum and growth factors. However, the expression of 43Q expanded protein strongly activated the ataxia telangiectasia mutated kinase/ATM and Rad3-related kinase (ATM/ATR)-dependent DNA damage response, as shown by selective phosphorylation of ATM substrates. This activation was dependent on 43 CAG protein expression, reversible and sensitive to caffeine and reducing agents. Similarly, we found phosphorylated ATM substrates in fibroblasts from Huntington's disease or SCA-2 patients. Oxidative stress induced accumulation of ATM/ATR phosphorylated protein in HD and SCA-2 patients, but not in normal controls. Furthermore, a significant phosphorylation of H2AX was shown by fibroblasts from patients. We conclude that polyglutamine induces ATM/ATR-dependent DNA damage response through accumulation of reactive oxygen species. ATM activation can be used to monitor the disease in vivo.
* To whom correspondence should be addressed at: Dipartimento di Biologia e Patologia Molecolare e Cellulare, Università Federico II, via Pansini 5, 80131, Napoli, Italy. Tel: +39 817463251; Fax: +39 817463252; Email: avvedim{at}unina.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Gardiner, D. Barton, R. Overall, and J. Marc Neurotrophic Support and Oxidative Stress: Converging Effects in the Normal and Diseased Nervous System Neuroscientist, February 1, 2009; 15(1): 47 - 61. [Abstract] [PDF] |
||||
![]() |
S. L. Anne, F. Saudou, and S. Humbert Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons J. Neurosci., July 4, 2007; 27(27): 7318 - 7328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, H. Ono, K. Mihara, H. Tauchi, K. Komatsu, T. Shibata, H. Shimizu, K. Uchida, and K.-i. Yamamoto ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. Genes Cells, July 1, 2006; 11(7): 779 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, P. J. Lim, C. Yin, M. Rieckher, B. E. Vogel, and M. J. Monteiro Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin Hum. Mol. Genet., March 15, 2006; 15(6): 1025 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perluigi, H. F. Poon, W. Maragos, W. M. Pierce, J. B. Klein, V. Calabrese, C. Cini, C. De Marco, and D. A. Butterfield Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice: A Model of Huntington Disease Mol. Cell. Proteomics, December 1, 2005; 4(12): 1849 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Toulouse, F. Au-Yeung, C. Gaspar, J. Roussel, P. Dion, and G. A. Rouleau Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts Hum. Mol. Genet., September 15, 2005; 14(18): 2649 - 2660. [Abstract] [Full Text] [PDF] |
||||




